A detailed history of X Square Capital, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, X Square Capital, LLC holds 313 shares of LLY stock, worth $260,882. This represents 0.09% of its overall portfolio holdings.

Number of Shares
313
Previous 311 0.64%
Holding current value
$260,882
Previous $257,000 5.06%
% of portfolio
0.09%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025

BUY
$713.71 - $898.95 $1,427 - $1,797
2 Added 0.64%
313 $244,000
Q1 2025

May 09, 2025

SELL
$725.72 - $929.72 $72,572 - $92,972
-100 Reduced 24.33%
311 $257,000
Q4 2024

Feb 12, 2025

BUY
$727.2 - $932.06 $298,879 - $383,076
411 New
411 $317,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $792B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track X Square Capital, LLC Portfolio

Follow X Square Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of X Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on X Square Capital, LLC with notifications on news.